MIT Technology Review highlights GT Moleculars’s role as the first to identify the signature for the SARS-CoV-2 UK variant in US sewersheds while helping communities track its progression
Feb 08, 2021 | Antonio Regalado
When the first reports of the B.1.1.7 variant emerged in December, GT Molecular, a company in Fort Collins, Colorado, was the first to reformat its sewage test to search for the variant. That involves checking sewage for two mutations characteristic of the B.1.1.7 strain.
QIAGEN and GT Molecular collaborate to offer a complete SARS-CoV-2 wastewater detection solution based on QIAcuity Digital PCR technology
When the first reports of the B.1.1.7 variant emerged in December, GT Molecular, a company in Fort Collins, Colorado, was the first to reformat its sewage test to search for the variant. That involves checking sewage for two mutations characteristic of the B.1.1.7 strain.
08.10.2021
Read More